Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Open Offer

27 Nov 2018 07:00

RNS Number : 5512I
Imaginatik PLC
27 November 2018
 

Imaginatik plc

("Imaginatik" or "the Company")

Result of Open Offer

 

On 2 November 2018 the Company announced details of an underwritten Open Offer to raise gross proceeds of up to approximately £252,578 through the issue of 22,961,687 new ordinary shares of £0.002 each ("Ordinary Shares") at 1.1 pence per share.

 

The Open Offer closed for acceptances at 11.00 a.m. on 26 November 2018 and the Company is pleased to announce that it has received valid acceptances under the Open Offer, including those received under the Excess Application Facility, in respect of 46,802,573 Ordinary Shares from Qualifying Shareholders. This represents demand for approximately 204 per cent. of the Open Offer Shares.

 

Qualifying Shareholders who have validly applied for Offer Shares will receive their Basic application in full and those Qualifying Shareholders who have validly applied for Excess Shares will receive approximately 33.10 per cent. of their Excess application on a pro rata basis, resulting in the issue of the full 22,961,687 Ordinary Shares under the Open Offer. Accordingly, the Company has not needed to call upon the underwriting facility.

 

Application has been made for the 22,961,687 new Ordinary Shares to be issued pursuant to the Open Offer to be admitted to trading on AIM. It is expected that admission of the new Ordinary Shares and commencement of dealings in the new Ordinary Shares will occur at 8.00 a.m. on 28 November 2018. Following Admission, the Enlarged Share Capital of the Company will consist of 71,949,673 Ordinary Shares. No Ordinary Shares are held in treasury.

 

The above figure of 71,949,673may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

This announcement should be read in conjunction with the full text of the Circular to Shareholders dated 2 November 2018, copies of which are available on the Company's website at www.imaginatik.com. Capitalised terms in this announcement have the same meaning as given in the Circular.

 

- ENDS -

 

For further information, please contact:

Imaginatik plc

Angus Forrest CEO

 

Via Alma PR (see contact details below)

WH Ireland - Nominated Adviser and joint broker

Mike Coe / Chris Savidge

 

Tel: +44 (0)117 945 3470

Peterhouse Capital Limited - Broker

Duncan Vasey / Lucy Williams

 

Tel: +44 (0) 20 7220 9797

Alma PR

Caroline Forde / Robyn Fisher

 

Tel: +44 (0) 20 8004 4218

 

About Imaginatik

 

Imaginatik is the only innovation solution provider which has combined a proven innovation program with purpose-built idea management software to enable companies to achieve breakthrough and continuous innovation at Imaginatik works with leading global enterprises to build and integrate innovation management skills as a core competency. Customers include ExxonMobil, Altria, TD Bank, Sodexo, Caterpillar and Cargill.

 

For more information visit www.imaginatik.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ROILFFLLLTLRFIT
Date   Source Headline
28th Jul 20154:07 pmRNSHolding(s) in Company
24th Jul 201512:50 pmRNSHolding(s) in Company
21st Jul 20155:31 pmRNSHolding(s) in Company
20th Jul 20157:00 amRNSSubscription and Director Dealings
15th Jul 20157:00 amRNSFinal Results
10th Jul 20159:23 amRNSHolding(s) in Company
1st Jul 20157:00 amRNSContract Win
29th Jun 20155:11 pmRNSHolding(s) in Company
29th Jun 20155:10 pmRNSHolding(s) in Company
29th Jun 201510:30 amRNSHolding(s) in Company
25th Jun 20157:00 amRNSHolding(s) in Company
25th Jun 20157:00 amRNSHolding(s) in Company
23rd Jun 20155:15 pmRNSHolding(s) in Company
23rd Jun 20157:00 amRNSHolding(s) in Company
22nd Jun 20157:00 amRNSMarket Update
1st Jun 20152:38 pmRNSResult of General Meeting
15th May 20157:00 amRNSPosting of Circular
14th May 20157:00 amRNSProposed Issue of Equity
13th Apr 20157:00 amRNSContract Wins
30th Mar 20157:00 amRNSContract Extension
16th Feb 20157:00 amRNSContracts win
11th Feb 20158:05 amRNSTrading Update
19th Jan 20157:00 amRNSDirector Loan
22nd Dec 201410:30 amRNSGrant of Options
17th Dec 20147:00 amRNSFive Year Contract Win
16th Dec 20147:00 amRNSContract Win
8th Dec 20147:00 amRNSInterim Results
19th Nov 20147:00 amRNSDirectorate Change
14th Nov 201411:52 amRNSBlocklisting Interim Review
24th Oct 20147:00 amRNSIssue of Equity/Director's Dealing
7th Oct 20145:04 pmRNSDirector/PDMR Shareholding
27th Aug 201410:50 amRNSHolding(s) in Company
21st Aug 20141:31 pmRNSDirector/PDMR Shareholding
18th Aug 20141:37 pmRNSHolding(s) in Company
14th Aug 20141:38 pmRNSResult of AGM
22nd Jul 20147:00 amRNSProposed Share Consolidation and Notice of AGM
1st Jul 20147:00 amRNSFinal Results
16th May 201411:40 amRNSHolding(s) in Company
15th May 20148:50 amRNSBlocklisting Interim Review
13th May 201411:47 amRNSHolding(s) in Company
12th May 20144:14 pmRNSResult of General Meeting and Exercise of Options
25th Apr 20147:00 amRNSProposed Placing and Subscription
14th Apr 20147:00 amRNSContract Wins and Trading Update
18th Mar 20147:00 amRNSContract Wins
28th Feb 201410:35 amRNSDirector's Dealing
26th Feb 201412:39 pmRNSDirector's Dealing
19th Dec 20133:38 pmRNSHolding(s) in Company
18th Dec 20137:00 amRNSExercise and Grant of Options
13th Dec 20137:00 amRNSContract Extension
3rd Dec 20137:00 amRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.